Health and Healthcare
Bristol-Myers Loses Out in Late-Stage Lung Cancer Study
Published:
Last Updated:
Bristol-Myers Squibb Co. (NYSE: BMY) shares dipped on Tuesday after the company reported results from its late-stage lung cancer study.
The firm announced that its Phase 3 CheckMate 451 study did not meet its primary endpoint of overall survival (OS) with Opdivo (nivolumab) in combination with Yervoy (ipilimumab) versus placebo as a maintenance therapy for patients with extensive-stage small cell lung cancer (SCLC) without disease progression after completion of first-line platinum-based chemotherapy.
No new safety signals were observed with Opdivo plus Yervoy in this study. The company will work with study investigators on the future publication of these results.
For some quick background: CheckMate 451 is a global, double-blind, randomized Phase 3 study evaluating Opdivo in combination with Yervoy and Opdivo monotherapy versus placebo as a maintenance therapy in patients with extensive-stage SCLC without disease progression after completion of first-line platinum-based chemotherapy.
The primary endpoint of the study was OS with Opdivo plus Yervoy versus placebo. The secondary endpoint is OS with Opdivo monotherapy versus placebo.
Shares of Bristol-Myers were last seen down about 3% at $51.00, with a 52-week range of $46.94 to $70.05. The stock has a consensus analyst price target of $60.06.
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
